- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Immunosyn Corp+ Add to Watchlist
IMYN:US0.0008 USD 0.00000.00%
As of 20:10:02 ET on 12/18/2014.
Company Profile for Immunosyn Corp (IMYN)
Immunosyn Corporation owns the exclusive worldwide license to market a biopharmaceutical drug used to treat chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers.
Key Executives for Immunosyn Corp (IMYN)
|Douglas A McClain JrChair/CFO/Chief Accounting Ofcr||Stephen D FerronePresident/CEO|